Voya Investment Management LLC Has $11.36 Million Stock Position in HealthEquity, Inc. $HQY
by Scott Moore · The Cerbat GemVoya Investment Management LLC cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 58.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 119,842 shares of the company’s stock after selling 169,475 shares during the period. Voya Investment Management LLC owned about 0.14% of HealthEquity worth $11,357,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the company. Norges Bank bought a new position in HealthEquity in the second quarter valued at about $75,072,000. Westfield Capital Management Co. LP raised its holdings in HealthEquity by 124.6% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after buying an additional 701,819 shares during the last quarter. AQR Capital Management LLC boosted its position in HealthEquity by 148.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after buying an additional 661,795 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in HealthEquity by 995.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock worth $56,500,000 after acquiring an additional 580,988 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its position in HealthEquity by 148.1% in the 1st quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company’s stock valued at $59,203,000 after acquiring an additional 399,897 shares during the period. 99.55% of the stock is currently owned by institutional investors.
Insider Activity at HealthEquity
In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of HealthEquity stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the transaction, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president directly owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 15,740 shares of company stock valued at $1,498,084. 1.50% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Several analysts recently weighed in on the stock. Citigroup reissued an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. KeyCorp reduced their price target on HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. JPMorgan Chase & Co. raised their price objective on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Royal Bank Of Canada upped their target price on HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, September 3rd. Finally, BTIG Research restated a “buy” rating and set a $130.00 price target on shares of HealthEquity in a report on Thursday, December 4th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $120.27.
View Our Latest Research Report on HQY
HealthEquity Trading Down 1.8%
NASDAQ HQY opened at $93.78 on Tuesday. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65. The business has a 50 day moving average price of $97.24 and a 200-day moving average price of $96.19. The company has a market cap of $8.01 billion, a price-to-earnings ratio of 43.02, a P/E/G ratio of 1.38 and a beta of 0.18.
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the previous year, the business posted $0.78 EPS. HealthEquity’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, equities analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.
HealthEquity Company Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Recommended Stories
- Five stocks we like better than HealthEquity
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?